PUBLIC VERSION
`
`UNITED STATES INTERNATIONAL TRADE COMMISSION
`WASHINGTON, D.C.
`
`In the Matter of
`CERTAIN LIGHT-BASED PHYSIOLOGICAL
`MEASUREMENT DEVICES AND
`COMPONENTS THEREOF
`
`Inv. No. 337-TA-1276
`
`RESPONDENT APPLE INC.’S RESPONSE TO
`COMPLAINANTS’ PETITION FOR REVIEW
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`
`
`PUBLIC VERSION
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`
`
`
`
`
`
`
`
`INTRODUCTION ...............................................................................................................1(cid:3)
`
`THE POEZE PATENTS (’501, ’502, ’648 patents) ............................................................3(cid:3)
`A.(cid:3)
`Issue No. 1: The ID Correctly Found ’501 Claim 12 Obvious. ..............................3(cid:3)
`1.(cid:3)
`Substantial Evidence Supports The ID’s Finding That Lumidigm
`Enabled Measuring Physiological Parameters. ............................................3(cid:3)
`The ID Made No Legal Errors, and Substantial Evidence Supports
`Its Finding That A POSITA Would Have Modified Lumidigm’s
`Sensor To Include A Convex Protrusion. ....................................................9(cid:3)
`The ID Made No Legal Error, A nd Substantial Evidence Supports
`Its Finding That Lumidigm’s Openings Are Configured To Avoid
`Light Piping “Through The Protrusion.” ...................................................14(cid:3)
`Issue No. 2: The ID Applied The Correct Law In Evaluating ’502 Claim
`28 Element [28G], And Substantial Evidence Supported Its Finding. ..................17(cid:3)
`Issue No. 3: The ID Applied The Correct Law In Analyzing The
`Protrusion Comprising A Convex Surface Elements Of The ’502 And ’648
`Claims, And Substantial Evidence Supports Its Findings. ....................................20(cid:3)
`Issue No. 4: Substantial Evidence Supports The ID’s Findings On The
`Lack Of Secondary Considerations. ......................................................................21(cid:3)
`1.(cid:3)
`The ID Properly Found There Is Insufficient Evidence Of
`Commercial Success Tied To The Claimed Invention. .............................21(cid:3)
`The ID’s Findings Of No Evidence of Skepticism Or Unexpected
`Results Regarding Convex Surfaces Were Correct. ..................................24(cid:3)
`The ID’s Finding That There Was No Skepticism Regarding Pulse
`Oximetry at the Wrist Relevant To The Obviousness Analysis Was
`Correct........................................................................................................28(cid:3)
`Issue No. 5: Substantial Evidence Supports The ID’s Findings That ’502
`Claim 28 And ’648 Claim 12 Are Invalid For Lack Of Written
`Description. ............................................................................................................29(cid:3)
`1.(cid:3)
`Dr. Warren’s Testimony Supports The Finding Of Lack Of Written
`Description. ................................................................................................30(cid:3)
`The Poeze Specification Supports The Finding Of Lack Of Written
`Description. ................................................................................................32(cid:3)
`
`B.(cid:3)
`
`C.(cid:3)
`
`D.(cid:3)
`
`E.(cid:3)
`
`2.(cid:3)
`
`3.(cid:3)
`
`2.(cid:3)
`
`3.(cid:3)
`
`2.(cid:3)
`
`U.S. PATENT NO. 10,687,745 .........................................................................................35(cid:3)
`A.(cid:3)
`Issue No. 6: The ID Made No “Legal Error” In Finding That
`Complainants Failed To Prove Infringement Of The ’745 Patent. ........................35(cid:3)
`Issue No. 7: The ID Correctly Assigned Little Weight To Apple’s Alleged
`Skepticism And Failures As Indicia Of Nonobviousness For The ’745
`Patent......................................................................................................................41(cid:3)
`
`B.(cid:3)
`
`
`
`(cid:3) I
`
`.(cid:3)
`
`II.(cid:3)
`
`III.(cid:3)
`
`
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`IV.(cid:3)
`
`V.(cid:3)
`
`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`C.(cid:3)
`
`Issue No. 8: The ID Correctly Found That No Evidence Of Commercial
`Success Weighs Against Obviousness Of The ’745 Patent. ..................................43(cid:3)
`
`TECHNICAL PRONG REGARDING MASIMO W1......................................................44(cid:3)
`A.(cid:3)
`Issue No. 9: The ID Properly Disregarded Post-Complaint Evidence
`Regarding The Masimo W1. ..................................................................................44(cid:3)
`1.(cid:3)
`The ID Properly Applied Commission Precedent To Disregard
`Post-Complaint Evidence...........................................................................45(cid:3)
`Commission Policy Should Require A Practicing Physical Article
`To Satisfy The Technical Prong. ...............................................................48(cid:3)
`Complainants Failed To Show That The Masimo W1 Practices The Poeze
`And ’745 Patents. ...................................................................................................48(cid:3)
`1.(cid:3)
`Complainants Failed To Show That The Masimo W1 Is
`“Configured” In The Manner Required By The Asserted Claims. ............49(cid:3)
`Complainants Did Not Provide Substantial Evidence That The W1
`Contained “Light Diffusing Material” As The ’745 Patent
`Requires. ....................................................................................................53(cid:3)
`
`2.(cid:3)
`
`2.(cid:3)
`
`B.(cid:3)
`
`U.S. PATENT NO. 7,761,127 ...........................................................................................54(cid:3)
`A.(cid:3)
`Issue No. 10: The ID Correctly Found That Complainants Failed To Prove
`Infringement Of The ’127 Patent. ..........................................................................54(cid:3)
`1.(cid:3)
`The ID Correctly Construed “A Thermal Mass” As Requiring A
`Mass That Stabilizes A Bulk Temperature. ...............................................55(cid:3)
`Complainants Failed To Prove Infringement Under The Proper
`Construction Of “A Thermal Mass.” .........................................................57(cid:3)
`The ID Correctly Construed “Bulk Temperature For The Thermal
`Mass” As A Representative Temperature For The Thermal Mass. ...........66(cid:3)
`Complainants Failed To Prove Infringement Under The Proper
`Construction Of “Bulk Temperature For The Thermal Mass.” .................67(cid:3)
`Issue No. 11: The ID Correctly Found That Complainants’ Current
`Rainbow Sensors Do Not Satisfy The Technical Prong For The ’127
`Patent......................................................................................................................69(cid:3)
`Issue No. 12: The ID Correctly Found No Commercial Success Based On
`Sales Of The Current Rainbow Sensors. ................................................................70(cid:3)
`
`2.(cid:3)
`
`3.(cid:3)
`
`4.(cid:3)
`
`B.(cid:3)
`
`C.(cid:3)
`
`VI.(cid:3)
`
`DOMESTIC INDUSTRY – ECONOMIC PRONG ..........................................................71(cid:3)
`A.(cid:3)
`Issue No. 13: The ID Correctly Excluded Complainants’ Unsubstantiated
`Expenditures. .........................................................................................................71(cid:3)
`1.(cid:3)
`The ID Correctly Excluded Complainants’ Stale And
`Unsubstantiated Wrist-Worn R&D Expenditures. .....................................72(cid:3)
`The ID Correctly Excluded Masimo’s Unsubstantiated Capital
`Expenditures. .............................................................................................76(cid:3)
`
`2.(cid:3)
`
`- ii -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`B.(cid:3)
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`3.(cid:3)
`
`The ID Correctly Excluded Complainants’ Contracts With Foreign
`Design Companies. ....................................................................................77(cid:3)
`The ID Correctly Excluded Complainants’ Unsubstantiated
`Manufacturing Expenditures. .....................................................................78(cid:3)
`Had The ID Applied The Same Standards To Complainants’ Other
`Expenditures, It Would Have Excluded Them As Well. ...........................78(cid:3)
`Issue No. 14: The ID Correctly Found The Economic Prong Not Satisfied
`For The ’127 Patent. ..............................................................................................81(cid:3)
`1.(cid:3)
`The ID Properly Disregarded Complainants’ Unreliable COGS
`Analysis......................................................................................................82(cid:3)
`The ID Properly Rejected Complainants’ Conclusory Claim
`Regarding Domestic Facility Investments. ................................................83(cid:3)
`
`4.(cid:3)
`
`5.(cid:3)
`
`2.(cid:3)
`
`VII.(cid:3) CONCLUSION ..................................................................................................................84(cid:3)
`
`
`
`
`
`
`
`
`
`- iii -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`TABLE OF AUTHORITIES
`
`C
`
`Cases
`
`Adang v. Umbeck,
`2007 WL 3120323 (Fed. Cir. 2007).........................................................................................31
`
`Adidas AG v. Nike, Inc.,
`963 F.3d 1355 (Fed. Cir. 2020)................................................................................................20
`
`Apple Inc. v. Samsung Electronics Co.,
`839 F.3d 1034 (Fed. Cir. 2016)........................................................................................ passim
`
`Asyst Techs., Inc. v. Emtrak, Inc.,
`544 F.3d 1310 (Fed. Cir. 2008)................................................................................................19
`
`Auris Health, Inc. v. Intuitive Surgical Operations, Inc.,
`32 F.4th 1154 (Fed. Cir. 2022) ................................................................................................42
`
`Bally/Midway Mfg. v. U.S. Int’l Trade Comm’n,
`714 F.2d 1117 (Fed. Cir. 1983)................................................................................................45
`
`In re Baxter Int’l, Inc.,
`678 F.3d 1357 (Fed. Cir. 2012)................................................................................................32
`
`Broadcom Corp. v. Int’l Trade Comm’n,
`542 F.3d 894 (Fed. Cir. 2008)..................................................................................................23
`
`Centocor Ortho Biotech, Inc. v. Abbott Labs.,
`636 F.3d 1341 (Fed. Cir. 2011)................................................................................................30
`
`Certain Beverage Brewing Capsules, Components Thereof, & Products
`Containing the Same, Inv. No. 337-TA-929, Commission Opinion, 2016 WL
`9751230 (Apr. 5, 2016) ......................................................................................................31, 32
`
`Certain Dental & Orthodontic Scanners,
`Inv. No. 337-TA-1144, Final Initial Determination (June 1, 2020) ........................................31
`
`Certain Digital Media Devices,
`Inv. No. 337-TA-882, Final Initial Determination (July 7, 2014) ...........................................72
`
`Certain Devices for Improving Uniformity Used in a Backlight Module,
`337-TA-805, Commission Opinion (May 17, 2013) ...............................................................35
`
`Certain Flocked Swabs,
`Inv. No. 337-TA-1279, Final Initial Determination (Oct. 28, 2022) .......................................31
`
`- iv -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`Certain Hybrid Electric Vehicles and Components Thereof,
`Inv. No. 337-1042, Notice of Investigation (Mar. 7, 2017) .....................................................17
`
`Certain Products Having Laminated Packaging, Laminated Packaging, &
`Components Thereof, Inv. No. 337-TA-874, Commission Opinion (Sept. 3,
`2013) ..................................................................................................................................77, 78
`
`Certain Stringed Musical Instruments & Components Thereof,
`Inv. No. 337-TA-586, Commission Opinion (May 16, 2008) .....................................74, 76, 77
`
`Certain Subsea Telecommunications Systems and Components Thereof,
`Inv. No. 337-TA-1098, Commissio Opinion (Oct. 21, 2019) .......................................... passim
`
`Certain Televisions, Remote Controls, & Components Thereof,
`Inv. No. 337-TA-1263, Commission Opinion, 2022 WL 17486245 (Nov. 30,
`2022) ......................................................................................................................45, 46, 47, 48
`
`Certain Television Sets, Television Receivers, Television Tuners, & Components
`Thereof, Inv. No. 337-TA-910, Commission Opinion, 2015 WL 6755093
`(Oct. 30, 2015) .............................................................................................................82, 83, 84
`
`Certain Video Security Equip. & Sys., Related Software, Components Therof, &
`Prods. Containing Same, Inv. No. 337-TA-1281, Initial Determination (Oct.
`
`Certain Wearable Electronic Devices with ECG Functionality,
`Inv. No. 337-TA-1266, Commission Opinion (Jan. 30, 2023) ................................................25
`
`Cisco Sys., Inc. v. Int’l Trade Comm’n,
`No., 2017-2289 (Fed. Cir. Sept. 22, 2017) ..............................................................................17
`
`In re Cyclobenzaprine Hydrochloride Extended–Release Capsule Patent Litig.,
`676 F.3d 1063 (Fed. Cir. 2012)........................................................................................ passim
`
`DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc.,
`567 F.3d 1314 (Fed. Cir. 2009)................................................................................................13
`
`Dominion Energy, Inc. v. Alstom Grid LLC,
`725 F. App’x 980 (Fed. Cir. 2018) ....................................................................................60, 62
`
`In re Epstein,
`32 F.3d 1559 (Fed. Cir. 1994)....................................................................................................7
`
`Ethicon Endo-Surgery, Inc. v. Covidien LP,
`812 F.3d 1023 (Fed. Cir. 2016)..........................................................................................22, 23
`
`Game & Tech. Co. v. Activision Blizzard Inc.,
`926 F.3d 1370 (Fed. Cir. 2019)................................................................................................20
`
`- v -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
`
`A
`
`N
`
`Genetics Inst., LLC v. Novartis Vaccines & Diagnostics, Inc.,
`665 F.3d 1291 (Fed. Cir. 2011)..........................................................................................27, 28
`
`In re Glatt Air Techniques, Inc.,
`630 F.3d 1026 (Fed. Cir. 2011)..........................................................................................29, 30
`
`Impax Labs., Inc. v. Aventis Pharms. Inc.,
`545 F.3d 1312 (Fed. Cir. 2008)..............................................................................................4, 5
`
`Impax Labs. Inc. v. Lannett Holdings Inc.,
`893 F.3d 1372 (Fed. Cir. 2018)..............................................................................................6, 7
`
`Infernal Technology, LLC v. Activision Blizzard Inc.,
`2023 WL 370602 (Fed. Cir. 2023)...........................................................................................30
`
`Intellecutal Ventures I LLC v. Motorola Mobility LLC,
`870 F.3d 1320 (Fed. Cir. 2017)..............................................................................61, 62, 63, 64
`
`Knoll Pharmaceutical Co. v. Teva Pharmaceuticals USA, Inc.,
`367 F.3d 1381 (Fed. Cir. 2004)................................................................................................27
`
`Koito Mfg. Co. v. Turn-Key-Tech. LLC,
`381 F.3d 1142 (Fed. Cir. 2004)................................................................................................31
`
`Koninklijke Philips N.V. v. Google LLC,
`948 F.3d 1330 (Fed. Cir. 2020)................................................................................................20
`
`KSR Int’l Co. v. Teleflex Inc.,
`550 U.S. 398 (2007) .................................................................................................................19
`
`In re Kuhle,
`526 F.2d 553 (C.C.P.A. 1975) .................................................................................................20
`
`In re Law,
`303 F.2d 951 (C.C.P.A. 1962) .................................................................................................19
`
`Lelo Inc. v. ITC,
`786 F.3d 879 (Fed. Cir. 2015)..................................................................................................82
`
`Lochner Technologies, LLC v. Apple Inc.,
`2013 WL 12113226 (C.D. Cal. June 6, 2013) .............................................................56, 57, 58
`
`In re Magna Electronics, Inc.,
`611 F. App’x 969 (Fed. Cir. 2015) ..........................................................................................20
`
`Motiva, LLC v. Int’l Trade Comm’n,
`716 F.3d 596 (Fed. Cir. 2013)..................................................................................................45
`
`- vi -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
`
`A
`
`N
`
`MRC Innovations, Inc. v. Hunter Mfg., LLP,
`747 F.3d 1326 (Fed. Cir. 2014)................................................................................................22
`
`Nobel Biocare Services AG v. Instradent USA, Inc.,
`903 F.3d 1365 (Fed. Cir. 2018)................................................................................................17
`
`OSRAM Sylvania, Inc. v. American Induction Techs., Inc.,
`701 F.3d 698 (Fed. Cir. 2012)..................................................................................................20
`
`Plantronics, Inc. v. Aliph, Inc.,
`724 F.3d 1343 (Fed Cir. 2013).................................................................................................25
`
`Process Control Corp. v. HydReclaim Corp.,
`190 F.3d 1350 (Fed. Cir. 1999)................................................................................................30
`
`In re Publicover,
`813 F. App’x 537 (Fed. Cir. 2020) ..........................................................................................16
`
`Railroad Dynamics, Inc. v. A. Stucki. Co.,
`727 F.2d 1506 (Fed. Cir. 1984)................................................................................................38
`
`Warner-Jenkinson Co. v. Hilton Davis Chem. Co.,
`520 U.S. 17 (1997) .............................................................................................................65, 66
`
`Wasica Finance GmbH v. Continental Automotive Sys.,
`853 F.3d 1272 (Fed. Cir. 2017)................................................................................................56
`
`WBIP, LLC v. Kohler Co.,
`829 F.3d 1317 (Fed. Cir. 2016)................................................................................................31
`
`Yoon Ja Kim v. ConAgra Foods, Inc.,
`465 F.3d 1312 (Fed. Cir. 2006)................................................................................................58
`
`Statutes and Regulations
`
`132 Cong. Rec. H 9965 ..................................................................................................................44
`
`- vii -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`TABLE OF ABBREVIATIONS
`
`’501 patent
`
`’502 patent
`
`’648 patent
`
`’745 patent
`
`U.S. Patent No. 10,912,501
`
`U.S. Patent No. 10,912,502
`
`U.S. Patent No. 10,945,648
`
`U.S. Patent No. 10,687,745
`
`’127 patent
`U.S. Patent No. 7,761,127
`“Poeze patents” U.S. Patent No. 10,912,501, U.S. Patent No. 10,912,502, and U.S. Patent
`No. 10,945,648
`
`Tr.
`
`Dep.
`
`JX
`
`CX
`
`CPX
`
`CDX
`
`RX
`
`RPX
`
`RDX
`
`CPHB
`
`CIB
`
`CRB
`
`RPHB
`
`RIB
`
`RRB
`
`CPFR
`
`Hearing Transcript
`
`Deposition Transcript
`
`Joint Exhibit
`
`Complainants’ Exhibit
`
`Complainants’ Physical Exhibit
`
`Complainants’ Demonstrative Exhibit
`
`Respondent’s Exhibit
`
`Respondent’s Physical Exhibit
`
`Respondent’s Demonstrative Exhibit
`
`Complainants’ Pre-Hearing Brief
`
`Complainants’ Initial Post-Hearing Brief
`
`Complainants’ Reply Post-Hearing Brief
`
`Respondent’s Pre-Hearing Brief
`
`Respondent’s Initial Post-Hearing Brief
`
`Respondent’s Reply Post-Hearing Brief
`
`Complainants’ Petition for Review
`
`- viii -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`TABLE OF ABBREVIATIONS
`
`RPFR
`
`Respondent’s Petition for Review
`
`
`
`
`
`
`
`
`
`- ix -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`TABLES OF CLAIM ELEMENT IDENTIFIERS
`
`
`Identifier
`
`[1
`Preamble]
`[1A]
`[1B]
`
`[1C]
`
`[1D]
`
`[1E]
`
`[1F]
`
`[12]
`
`U.S. Patent No. 10,912,501
`Claim/Element
`Claim 12
`A user-worn device configured to noninvasively measure a physiological
`parameter of a user, the user-worn device comprising:
`at least three light emitting diodes (LEDs);
`at least three photodiodes arranged on an interior surface of the user-worn
`device and configured to receive light attenuated by tissue of the user;
`a protrusion arranged over the interior surface, the protrusion comprising a
`convex surface and
`a plurality of openings extending through the protrusion and positioned over
`the three photodiodes,
`the openings each comprising an opaque lateral surface, the plurality of
`openings configured to allow light to reach the photodiodes, the opaque lateral
`surface configured to avoid light piping through the protrusion; and
`one or more processors configured to receive one or more signals from the
`photodiodes and calculate a measurement of the physiological parameter of the
`user.
`The user-worn device of Claim 1, wherein the convex surface of the protrusion
`is an outermost surface configured to contact the tissue of the user and
`conform the tissue into a concave shape.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`- x -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`Identifier
`
`[19A]
`
`[19B]
`
`[19C]
`
`U.S. Patent No. 10,912,502
`Claim/Element
`Claim 22
`[19 Preamble] A user-worn device configured to non-invasively measure an oxygen
`saturation of a user, the user worn device comprising:
`a plurality of emitters configured to emit light, each of the emitters
`comprising at least two light emitting diodes (LEDs);
`four photodiodes arranged within the user-worn device and configured to
`receive light after at least a portion of the light has been attenuated by tissue
`of the user;
`a protrusion comprising a convex surface including separate openings
`extending through the protrusion and lined with opaque material, each
`opening positioned over a different one of the four photodiodes, the opaque
`material configured to reduce an amount of light reaching the photodiodes
`without being attenuated by the tissue;
`optically transparent material within each of the openings; and
`one or more processors configured to receive one or more signals from at
`least one of the four photodiodes and output measurements responsive to the
`one or more signals, the measurements indicative of the oxygen saturation of
`the user.
`The user-worn device of claim 19 further comprising a thermistor.
`The user-worn device of claim 20, wherein the one or more processors are
`further configured to receive a temperature signal from the thermistor and
`adjust operation of the user-worn device responsive to the temperature
`signal.
`The user-worn device of claim 21, wherein the plurality of emitters comprise
`at least four emitters, and wherein each of the plurality of emitters comprises
`a respective set of at least three LEDs.
`
`[19D]
`[19E]
`
`[20]
`[21]
`
`[22]
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`- xi -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
`
`A
`
`N
`
`Identifier
`
`[28A]
`
`[28B]
`
`[28C]
`
`[28D]
`[28E]
`
`[28F]
`
`[28G]
`
`[28H]
`
`U.S. Patent No. 10,912,502
`Claim/Element
`Claim 28
`[28 Preamble] A user-worn device configured to non-invasively measure an oxygen
`saturation of a user, the user worn device comprising:
`a first set of light emitting diodes (LEDs), the first set of LEDs comprising at
`least an LED configured to emit light at a first wavelength and an LED
`configured to emit light at a second wavelength;
`a second set of LEDs spaced apart from the first set of LEDs, the second set
`of LEDs comprising at least an LED configured to emit light at the first
`wavelength and an LED configured to emit light at the second wavelength;
`four photodiodes arranged in a quadrant configuration on an interior surface
`of the user-worn device and configured to receive light after at least a portion
`of the light has been attenuated by tissue of the user;
`a thermistor configured to provide a temperature signal;
`a protrusion arranged above the interior surface, the protrusion comprising: a
`convex surface;
`a plurality of openings in the convex surface, extending through the
`protrusion, and aligned with the four photodiodes, each opening defined by
`an opaque surface configured to reduce light piping; and
`a plurality of transmissive windows, each of the transmissive windows
`extending across a different one of the openings;
`at least one opaque wall extending between the interior surface and the
`protrusion, wherein at least the interior surface, the opaque wall and the
`protrusion form cavities, wherein the photodiodes are arranged on the
`interior surface within the cavities;
`one or more processors configured to receive one or more signals from at
`least one of the photodiodes and calculate an oxygen saturation measurement
`of the user, the one or more processors further configured to receive the
`temperature signal;
`a network interface configured to wirelessly communicate the oxygen
`saturation measurement to at least one of a mobile phone or an electronic
`network;
`a user interface comprising a touch-screen display, wherein the user interface
`is configured to display indicia responsive to the oxygen saturation
`measurement of the user;
`a storage device configured to at least temporarily store at least the
`measurement; and
`a strap configured to position the user-worn device on the user.
`
`[28I]
`
`[28J]
`
`[28K]
`
`[28L]
`
`[28M]
`
`- xii -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
`
`A
`
`N
`
`Identifier
`
`[8A]
`
`[8B]
`
`[8C]
`[8D]
`
`[8E]
`
`[8F]
`
`[8G]
`
`[8H]
`[8I]
`
`[12]
`
`U.S. Patent No. 10,945,648
`Claim/Element
`Claim 12
`[8 Preamble] A user-worn device configured to non-invasively determine measurements of
`a physiological parameter of a user, the user-worn device comprising:
`a first set of light emitting diodes (LEDs), the first set comprising at least an
`LED configured to emit light at a first wavelength and at least an LED
`configured to emit light at a second wavelength;
`a second set of LEDs spaced apart from the first set of LEDs, the second set
`of LEDs comprising an LED configured to emit light at the first wavelength
`and an LED configured to emit light at the second wavelength;
`four photodiodes;
`a protrusion comprising a convex surface, at least a portion of the protrusion
`comprising an opaque material;
`a plurality of openings provided through the protrusion and the convex
`surface, the openings aligned with the photodiodes;
`a separate optically transparent window extending across each of the
`openings;
`one or more processors configured to receive one or more signals from at
`least one of the photodiodes and output measurements of a physiological
`parameter of a user;
`a housing; and
`a strap configured to position the housing proximate tissue of the user when
`the device is worn.
`The user-worn device of Claim 8, wherein the physiological parameter
`comprises oxygen or oxygen saturation.
`Claim 24
`[20 Preamble] A user-worn device configured to non-invasively determine measurements of
`a user’s tissue, the user-worn device comprising:
`a plurality of light emitting diodes (LEDs);
`at least four photodiodes configured to receive light emitted by the LEDs, the
`four photodiodes being arranged to capture light at different quadrants of
`tissue of a user;
`a protrusion comprising a convex surface and
`a plurality of through holes, each through hole including a window and
`arranged over a different one of the at least four photodiodes; and
`one or more processors configured to receive one or more signals from at
`least one of the photodiodes and determine measurements of oxygen
`saturation of the user.
`The user-worn device of Claim 20, wherein the protrusion comprises opaque
`material configured to substantially prevent light piping.
`
`[20A]
`[20B]
`
`[20C]
`[20D]
`
`[20E]
`
`[24]
`
`- xiii -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`
`
`
`
`
`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`Identifier
`
`[20A]
`[20B]
`
`U.S. Patent No. 10,945,648
`Claim/Element
`Claim 30
`[20 Preamble] A user-worn device configured to non-invasively determine measurements of
`a user’s tissue, the user-worn device comprising:
`a plurality of light emitting diodes (LEDs);
`at least four photodiodes configured to receive light emitted by the LEDs, the
`four photodiodes being arranged to capture light at different quadrants of
`tissue of a user;
`a protrusion comprising a convex surface and
`a plurality of through holes, each through hole including a window and
`arranged over a different one of the at least four photodiodes; and
`one or more processors configured to receive one or more signals from at
`least one of the photodiodes and determine measurements of oxygen
`saturation of the user.
`The user-worn device of Claim 20, wherein the protrusion further comprises
`one or more chamfered edges.
`
`[20C]
`[20D]
`
`[20E]
`
`[30]
`
`
`
`- xiv -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
` A
`
`
`
`
`
`N
`
`
`
`
`
`
`
`Identifier
`
` [1
`Preamble]
` [1A]
` [1B]
`
` [1C]
`
` [1D]
`
` [1E]
`
` [1F]
`
`[9]
`
`U.S. Patent No. 10,687,745
`Claim/Element
`Claim 9
`A physiological monitoring device comprising:
`
`a plurality of light-emitting diodes configured to emit light in a first shape;
`a material configured to be positioned between the plurality of light-emitting
`diodes and tissue on a wrist of a user when the physiological monitoring
`device is in use, the material configured to change the first shape into a second
`shape by which the light emitted from one or more of the plurality of light-
`emitting diodes is projected towards the tissue;
`a plurality of photodiodes configured to detect at least a portion of the light
`after the at least the portion of the light passes through the tissue, the plurality
`of photodiodes further configured to output at least one signal responsive to
`the detected light;
`a surface comprising a dark-colored coating, the surface configured to be
`positioned between the plurality of photodiodes and the tissue when the
`physiological monitoring device is in use, wherein an opening defined in the
`dark-colored coating is configured to allow at least a portion of light reflected
`from the tissue to pass through the surface;
`a light block configured to prevent at least a portion of the light emitted from
`the plurality of light-emitting diodes from reaching the plurality of
`photodiodes without first reaching the tissue;
`and a processor configured to receive and process the outputted at least one
`signal and determine a physiological parameter of the user responsive to the
`outputted at least one signal.
`The physiological monitoring device of claim 1, wherein the physiological
`parameter comprises oxygen saturation.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`- xv -
`
`MASIMO 2075
`Apple v. Masimo
`IPR2022-01291
`
`

`

`C
`
`PUBLIC VERSION
`
`A
`
`N
`
`Identifier
`
` [15
`Preamble]
`[15A]
`
` [15B]
`
` [15C]
` [15D]
`
` [15E]
`
` [15F]
`
` [15G]
`
` [15H]
`
` [15I]
`
`[18]
`
`U.S. Patent No. 10,687,745
`Claim/Element
`Claim 18
`A physiological monitoring device comprising:
`
`a plurality of light-emitting diodes configured to emit light proximate a wrist
`of a user;
`a light diffusing material configured to be positioned between the plurality of
`light-emitting diodes and a tissue measurement site on the wrist of the user
`when the physiological monitoring device is in use;
`a light block having a circular shape;
`a plurality of photodiodes configured to detect at least a portion of the light
`emitted from the plurality of light-emitting diodes after the light passes
`through the light diffusing material and a portion of the tissue measurement
`site encircled by the light block, wherein the plurality of photodiodes are
`arranged in an array having a spatial configuration corresponding to a shape
`of the portion